To provide a new compound usable for treating disorders, in particular, cardiovascular and blood disorders.
The invention provides the followings: dihydropyrazolone derivatives represented by formula (I) and their production method; use of them for treating and/or preventing disorders; and use of them for production of medicines for treatment and/or prevention of disorders, in particular cardiovascular and blood disorders, and renal disorders, and for facilitation of wound healing. The compound acts as a specific inhibitor against HIF prolyl 4-hydroxylase and brings, on the basis of the specific action mechanism, biological processes derived therefrom, for example, induction of HIF target genes such as erythropoietin and, for example, erythropoiesis in vivo, after parenteral or oral administration.
FLAMME INGO
OEHME FELIX
ERGUEDEN JENS-KERIM
STOLL FRIEDERIKE
SCHUHMACHER JOACHIM
WILD HANNO
KOLKHOF PETER
BECK HARTMUT
KELDENICH JOERG
AKBABA METIN
JESKE MARIO
JPH10306077A | 1998-11-17 | |||
JPS61137878A | 1986-06-25 | |||
JPH10306077A | 1998-11-17 | |||
JPS61137878A | 1986-06-25 |
WO2005030121A2 | 2005-04-07 | |||
US20030083351A1 | 2003-05-01 | |||
WO2005030121A2 | 2005-04-07 | |||
US20030083351A1 | 2003-05-01 |
Takuji Yamada
Michiko Matsutani
Mitsutaka Iwasaki
Yasushi Ochiai
Next Patent: PHARMACEUTICAL COMPOSITION